LASP1 (LIM and SH3 protein 1) is a multifunctional scaffolding protein that plays critical roles in cytoskeletal organization and cell signaling. Structurally, LASP1 contains an N-terminal LIM domain and C-terminal SH3 domain, enabling interactions with diverse binding partners 1. Its primary function involves regulating actin-based cytoskeletal dynamics and coordinating localized signaling events through its scaffolding capacity 2. LASP1 demonstrates nuclear translocation capability, allowing signal transmission from cytoplasm to nucleus 1. Mechanistically, LASP1 functions as a molecular platform linking signaling cascades. In neuroendocrine prostate cancer, CXCR4 activation promotes LASP1 nuclear translocation, where it bridges G9a and SNAIL to repress REST transcription, driving epithelial-mesenchymal transition 3. LASP1 also regulates protein stability through proteasomal degradation pathways; it interacts with GLUD1 and recruits E3 ligase SYVN1 for GLUD1 ubiquitination and degradation in hepatocellular carcinoma 4. Clinically, LASP1 overexpression correlates with poor prognosis across multiple cancer types, with expression levels associated with tumor grade, size, and metastatic potential 5. Recent genome-wide association studies identified LASP1 as a genetic locus nominally associated with Alzheimer's disease 6. LASP1 elevation promotes cancer cell proliferation, migration, and invasion, and facilitates drug resistance through metabolic dysregulation 7. These properties establish LASP1 as both a mechanistic driver of cancer aggressiveness and a potential biomarker for disease progression.